Bosentan 70771-1908-08
- Manufacturer
- Zydus Lifesciences Limited
- Dosage Form
- Tablet, For Suspension
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- February 17, 2026
- Listing Expires
- December 31, 2027
- Application
- ANDA213981
Need to source Bosentan? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Bosentan | 32 mg/1 |
Drug Class
Cytochrome P450 2C9 Inducers [MoA]Cytochrome P450 3A Inducers [MoA]Endothelin Receptor Antagonist [EPC]
Selected Package
70771-1908-08Selected4 BLISTER PACK in 1 CARTON (70771-1908-8) / 14 TABLET, FOR SUSPENSION in 1 BLISTER PACK (70771-1908-7)